OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Daver on Anticipated Breakthroughs in AML

May 15th 2020

Naval G. Daver, MD, discusses anticipated breakthroughs in acute myeloid leukemia (AML).

Dr. Penson on Ongoing Research in Prostate Cancer

May 15th 2020

David F. Penson, MD, MPH, MMHC, discusses ongoing research in prostate cancer.

Dr. Dahut on the Future of Genetic Screening in Prostate Cancer

May 15th 2020

William L. Dahut, MD, discusses the future of genetic screening in prostate cancer.

Dr. Huh on SGO COVID-19 Task Force Efforts

May 15th 2020

Warner K. Huh, MD, discusses some of the key challenges faced in the management of gynecologic cancers in light of the COVID-19 crisis, shares some of the resources provided by the SGO COVID-19 task force, and projects what is needed to quell the pandemic, which he refers to as version of the Great Depression.

Dr. Wright on Radiation Considerations in Breast Cancer

May 15th 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

Dr. Natale on the Evolution of Immunotherapy in NSCLC

May 15th 2020

Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.

Dr. Zelenetz on Progress Made in MCL Treatment

May 15th 2020

Andrew D. Zelenetz, MD, PhD, discusses progress made in mantle cell lymphoma treatment.

Dr. Noy on Next Phase of a Trial With Devimistat in Relapsed/Refractory Burkitt Lymphoma

May 15th 2020

Ariela Noy, MD, discusses the next phase of a trial with devimistat in patients with relapsed/refractory Burkitt lymphoma.

Dr. Daver on Anticipated Breakthroughs in AML

May 15th 2020

Naval G. Daver, MD, discusses anticipated breakthroughs in acute myeloid leukemia (AML).

Dr. Ghorbrial on the Potential Utility of Triplet Therapy in Smoldering Multiple Myeloma

May 15th 2020

Irene Ghobrial, MD, discusses the potential utility of triplet therapy in smoldering multiple myeloma.

Dr. Penson on Ongoing Research in Prostate Cancer

May 14th 2020

David F. Penson, MD, MPH, MMHC, discusses ongoing research in prostate cancer.

Dr. Dahut on the Future of Genetic Screening in Prostate Cancer

May 14th 2020

William L. Dahut, MD, discusses the future of genetic screening in prostate cancer.

The Rationale for Investigating DNA-PK as a Target in Prostate Cancer

May 14th 2020

Karen E. Knudsen, PhD, discusses the rationale for investigating DNA-dependent protein kinase as a target in prostate cancer.

Dr. Huh on SGO COVID-19 Task Force Efforts

May 14th 2020

Dr. Bose on Novel Agents Under Investigation in Myelofibrosis

May 14th 2020

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Dr. Iyer on TRAEs With Erdafitinib in Urothelial Cancer

May 14th 2020

Gopa Iyer, MD, discusses treatment-related adverse events (TRAEs) with erdafitinib (Balversa) in urothelial cancer.

Dr. Pagel on the Implications of Polatuzumab Vedotin Approval in DLBCL

May 14th 2020

John M. Pagel, MD, PhD, discusses the implications of the FDA approval of polatuzumab vedotin in diffuse large B-cell lymphoma.

Dr. Wang on the Evolution of Treatment in MCL

May 14th 2020

Michael Wang, MD, discusses the evolution of treatment in mantle cell lymphoma.

Dr. Smith on Frontline Treatment Options in MCL

May 14th 2020

Sonali M. Smith, MD, discusses frontline treatment options in mantle cell lymphoma.

Dr. Rugo on Takeaways From the IMpassion130 Trial in TNBC

May 14th 2020

Hope S. Rugo, MD, discusses takeaways from the phase 3 IMpassion130 trial in metastatic triple-negative breast cancer.